Published in Cancer Chemother Pharmacol on January 01, 1992
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res (1994) 11.29
Clinical implications of the p53 tumor-suppressor gene. N Engl J Med (1993) 7.29
p53 and human cancer: the first ten thousand mutations. Adv Cancer Res (2000) 4.71
IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res (1998) 3.74
Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut (2010) 3.24
Methanogenesis in a Thermophilic (58 degrees C) Anaerobic Digestor: Methanothrix sp. as an Important Aceticlastic Methanogen. Appl Environ Microbiol (1984) 2.69
A new Salmonella tester strain (TA102) with A X T base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci U S A (1982) 2.67
Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J Immunol (1998) 2.22
Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res (1997) 2.17
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther (2011) 2.12
A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol (2001) 1.86
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer (1996) 1.82
Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology (1995) 1.76
Diagnostic criteria for facioscapulohumeral muscular dystrophy. Neuromuscul Disord (1991) 1.75
Comparative genome analysis reveals extensive conservation of genome organisation for Arabidopsis thaliana and Capsella rubella. Plant J (2000) 1.74
Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res (2000) 1.73
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
C4d in acute rejection after liver transplantation--a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant (2006) 1.62
Short-term tests for carcinogens and mutagens. Mutat Res (1979) 1.62
Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J Virol (1998) 1.58
Evolution of clinical behaviour in Crohn's disease: predictive factors of penetrating complications. Dig Liver Dis (2005) 1.58
Observation of squeezed light from one atom excited with two photons. Nature (2011) 1.57
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene (2001) 1.57
Epidemiology of neural tube defects in Germany. Hum Genet (1984) 1.56
Localization of a human Na+,K+-ATPase alpha subunit gene to chromosome 19q12----q13.2 and linkage to the myotonic dystrophy locus. Genomics (1988) 1.55
In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum. Antimicrob Agents Chemother (1994) 1.55
Geographic variation of p53 mutational profile in nonmalignant human liver. Science (1994) 1.51
Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br J Surg (2014) 1.50
Is Lorazepam a treatment for neuroleptic malignant syndrome? CNS Spectr (2000) 1.50
Laminin expression in adult and developing retinae: evidence of two novel CNS laminins. J Neurosci (2000) 1.49
Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of randomized controlled trials. Dig Liver Dis (2008) 1.49
EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics (1998) 1.49
Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor. Virology (1995) 1.46
Identification of HER-2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia. Lung Cancer (2001) 1.46
Evidence for coupled transport of bicarbonate and sodium in cultured bovine corneal endothelial cells. J Membr Biol (1984) 1.42
The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol (2014) 1.41
Diet does not ensure normal development in galactosemia. J Am Coll Nutr (1997) 1.40
Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg (2009) 1.39
Type II diabetes mellitus: is the renal risk adequately appreciated? Nephrol Dial Transplant (1991) 1.39
Clinical implications of the p53 gene. Annu Rev Med (1996) 1.38
Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res (2001) 1.37
Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries. Int J Cancer (1987) 1.37
Halobacterial glycoprotein saccharides contain covalently linked sulphate. FEBS Lett (1980) 1.36
Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J Biol Chem (2000) 1.34
Evolution of enzymatic activities in the enolase superfamily: characterization of the (D)-glucarate/galactarate catabolic pathway in Escherichia coli. Biochemistry (1998) 1.33
Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care. Crit Care Med (2000) 1.32
Elucidation of the mechanism enabling tumor selective prodrug monotherapy. Cancer Res (1998) 1.32
Evaluation of leaf water status by means of permittivity at terahertz frequencies. J Biol Phys (2009) 1.29
Radiation dose and leukemia risk in patients treated for cancer of the cervix. J Natl Cancer Inst (1987) 1.28
Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus. Endoscopy (2007) 1.24
The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology (1994) 1.24
Relational pathways between socioeconomic position and cardiovascular risk in a multiethnic urban sample: complexities and their implications for improving health in economically disadvantaged populations. J Epidemiol Community Health (2008) 1.23
Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia (1997) 1.23
Identification of an essential Caulobacter crescentus gene encoding a member of the Obg family of GTP-binding proteins. J Bacteriol (1997) 1.21
MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol (1996) 1.20
Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood (2000) 1.19
Maxillonasal dysplasia (Binder's syndrome) J Med Genet (1990) 1.18
Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg (2000) 1.18
Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res (2001) 1.17
Interaction of poliovirus with its cell surface binding site. Virology (1994) 1.16
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br J Cancer (2009) 1.16
Sex and parental experience determine the onset of an instinctive behavior in mice. Naturwissenschaften (1987) 1.15
Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst (1995) 1.15
Detection of astrovirus in pediatric stool samples by immunoassay and RNA probe. J Clin Microbiol (1991) 1.14
Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol (1994) 1.14
Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer (1997) 1.13
Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. Oncogene (2007) 1.13
Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem (1990) 1.13
Regulation of extracellular matrix synthesis by mechanical stress. Biochem Cell Biol (1996) 1.11
Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-kappaB directs expression of the homing receptor BLR1 to mature B cells. J Biol Chem (1998) 1.11
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol (1992) 1.11
Tissue-specific expression of the fibril-associated collagens XII and XIV. J Cell Sci (1994) 1.11
Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg (2011) 1.10
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther (1995) 1.09
Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J Neurol (2008) 1.09
Interaction of yeast kinetochore proteins with centromere-protein/transcription factor Cbf1. Proc Natl Acad Sci U S A (2000) 1.09
Making the most of Papua New Guinea's biodiversity: Establishment of an integrated set of programs that link botanical survey with pharmacological assessment in "The Land of the Unexpected" Pharm Biol (2009) 1.08
Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients. Nucleic Acids Res (1986) 1.08
Ethics and triage. Prehosp Disaster Med (2001) 1.08
Transcriptome analysis identifies genes with enriched expression in the mouse central extended amygdala. Neuroscience (2008) 1.07
[Hypothermia in mountaineering. Apropos of 18 cases]. Chirurgie (1977) 1.07
Identification of novel striatal genes by expression profiling in adult mouse brain. Neuroscience (2007) 1.05
Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Klin Wochenschr (1988) 1.04
The frameshift mutation oscillator (Glra1(spd-ot)) produces a complete loss of glycine receptor alpha1-polypeptide in mouse central nervous system. Neuroscience (1997) 1.04
Comparison of the serology, transforming ability, and polypeptide composition of human papovaviruses isolated from urine. J Virol (1976) 1.04
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene (2007) 1.03
Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J Cancer Res Clin Oncol (1992) 1.02
Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res (1999) 1.02
Neurodevelopmental animal models of schizophrenia: effects on prepulse inhibition. Curr Mol Med (2003) 1.02
The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology (2001) 1.02
Identification of a nuclear respiratory factor-1 binding site within the core promoter of the human polio virus receptor/CD155 gene. J Biol Chem (2000) 1.01
Medical THz imaging: an investigation of histo-pathological samples. Phys Med Biol (2002) 1.01
Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes (1998) 1.01
Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog (1993) 1.01
Urinary tract infection in men. Int J Clin Pharmacol Ther (2004) 1.00
Cardiotoxicity and other adverse events associated with mitoxantrone treatment for MS. Neurology (2010) 1.00
The cannabinoid agonist WIN 55,212-2 reduces sensorimotor gating and recognition memory in rats. Behav Pharmacol (2002) 1.00